- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
670
Companies which are more than 50% undervalued based on analyst price target.
670 companies
Bionano Genomics
Market Cap: US$17.0m
Provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
BNGO
US$3.99
7D
5.8%
1Y
-85.0%
Evaxion
Market Cap: US$17.0m
A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
EVAX
US$2.92
7D
6.2%
1Y
-83.1%
MetaVia
Market Cap: US$16.6m
A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.
MTVA
US$0.69
7D
8.8%
1Y
-80.3%
Aelis Farma
Market Cap: €13.8m
A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.
AELIS
€1.02
7D
-11.7%
1Y
-82.8%
iBio
Market Cap: US$15.9m
A preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases.
IBIO
US$0.83
7D
2.1%
1Y
-53.1%
Cellectar Biosciences
Market Cap: US$15.9m
A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
CLRB
US$4.98
7D
2.3%
1Y
-92.0%
Alzinova
Market Cap: SEK 148.6m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 1.42
7D
11.3%
1Y
-59.5%
Chemomab Therapeutics
Market Cap: US$15.8m
A clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States.
CMMB
US$3.09
7D
-1.6%
1Y
-59.2%
Longeveron
Market Cap: US$15.8m
A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.
LGVN
US$0.79
7D
-4.4%
1Y
-59.8%
Lipocine
Market Cap: US$15.7m
A clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders.
LPCN
US$2.89
7D
-0.7%
1Y
-21.0%
Alligator Bioscience
Market Cap: SEK 146.2m
A research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Finland and Sweden.
ATORX
SEK 4.20
7D
-0.5%
1Y
-99.7%
Cocrystal Pharma
Market Cap: US$15.0m
A biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.
COCP
US$1.48
7D
-1.7%
1Y
-13.2%
Valbiotis
Market Cap: €12.8m
Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.
ALVAL
€0.80
7D
-6.5%
1Y
-46.3%
IXICO
Market Cap: UK£11.0m
Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.
IXI
UK£0.12
7D
-3.3%
1Y
24.7%
Imunon
Market Cap: US$14.4m
A clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines.
IMNN
US$5.76
7D
-3.0%
1Y
-57.6%
Pharma-Bio Serv
Market Cap: US$13.8m
Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.60
7D
0%
1Y
-7.7%
BiomX
Market Cap: US$13.7m
A clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases.
PHGE
US$0.52
7D
-4.2%
1Y
-56.6%
Adaptimmune Therapeutics
Market Cap: US$13.5m
A commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.
ADAP
US$0.041
7D
-30.4%
1Y
-96.2%
Intensity Therapeutics
Market Cap: US$13.4m
A late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States.
INTS
US$0.28
7D
0.04%
1Y
-92.8%
Carisma Therapeutics
Market Cap: US$13.4m
A biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States.
CARM
US$0.40
7D
86.9%
1Y
-59.8%
Vivesto
Market Cap: SEK 125.1m
Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.
VIVE
SEK 0.23
7D
-2.9%
1Y
-9.2%
NextCure
Market Cap: US$13.2m
A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.
NXTC
US$4.85
7D
-3.6%
1Y
-71.5%
Soligenix
Market Cap: US$13.0m
A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.
SNGX
US$2.86
7D
-7.7%
1Y
-23.5%
BioRestorative Therapies
Market Cap: US$13.0m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.60
7D
-13.0%
1Y
4.6%
NextCell Pharma
Market Cap: SEK 120.1m
A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.
NXTCL
SEK 1.08
7D
-7.9%
1Y
-30.9%
Kancera
Market Cap: SEK 112.7m
Develops drugs for inflammatory diseases and cancer in Sweden and internationally.
KAN
SEK 0.93
7D
-1.1%
1Y
-57.3%
BioVie
Market Cap: US$12.0m
A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States.
BIVI
US$1.74
7D
14.5%
1Y
-93.0%
BioCardia
Market Cap: US$11.8m
A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.
BCDA
US$2.06
7D
4.2%
1Y
-9.3%
Phio Pharmaceuticals
Market Cap: US$11.8m
A a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.
PHIO
US$2.04
7D
3.6%
1Y
-21.8%
Nanologica
Market Cap: SEK 109.6m
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.
NICA
SEK 1.24
7D
-11.7%
1Y
-52.1%
Moleculin Biotech
Market Cap: US$11.5m
A late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses.
MBRX
US$0.38
7D
-4.4%
1Y
-84.4%
Lyra Therapeutics
Market Cap: US$11.3m
A clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis.
LYRA
US$6.85
7D
-2.1%
1Y
-49.8%
Lipigon Pharmaceuticals
Market Cap: SEK 104.5m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.17
7D
-7.0%
1Y
-32.1%
Marker Therapeutics
Market Cap: US$11.1m
A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.
MRKR
US$0.90
7D
-3.1%
1Y
-69.9%
Sensei Biotherapeutics
Market Cap: US$11.1m
A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
SNSE
US$8.32
7D
-0.4%
1Y
-31.7%
Evoke Pharma
Market Cap: US$11.0m
Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
EVOK
US$5.21
7D
-4.4%
1Y
34.6%